Ayurvedic Treatment Package in Plaque Psoriasis
A Randomized Open Label Clinical Trial on the Efficacy of an Ayurvedic Treatment Package on Symptom Severity and Quality of Life in Plaque Psoriasis
1 other identifier
interventional
90
1 country
1
Brief Summary
Psoriasis is a chronic, immune-mediated inflammatory skin disease that is associated with substantial impairment of physical and psychological quality of life. The conventional treatment protocols manages the condition but with remissions and relapses which create anxiety in patients. Many of the patients withdraw from active social life as the disease attains chronicity. Several studies are pointing towards a conjoint management strategy incorporating the traditional and alternate medical systems. In this regard, Ayurveda is commonly used by psoriatic patients in India. Considering this fact it is high time to conduct a study to scientifically evaluate the efficacy of Ayurvedic treatment protocol in managing psoriasis as well as its potential to improve the quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Dec 2019
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2019
CompletedFirst Posted
Study publicly available on registry
October 31, 2019
CompletedStudy Start
First participant enrolled
December 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJune 15, 2025
June 1, 2025
3.6 years
October 29, 2019
June 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Psoriasis-specific quality of life
Psoriasis specific DLQI scores
6 months
Secondary Outcomes (8)
Psoriasis Severity
3 months
Psoriasis Severity
6 months
Psoriasis Severity
12 months
Psoriasis-specific quality of life
3 months
Psoriasis-specific quality of life
12 months
- +3 more secondary outcomes
Study Arms (2)
Internal ayurvedic treatment
EXPERIMENTALAll possible internal preparations will be administered for a period of 12 months. All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration
External ayurvedic treatment
ACTIVE COMPARATORApplication of warm external oil (Ayyapala kera tailam) on affected parts twice daily
Interventions
All possible internal preparations will be administered for a period of 12 months. All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration
Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily
Eligibility Criteria
You may qualify if:
- Patients with psoriasis having age 18 years or more
- Patients with moderate-to-severe plaque psoriasis with a PASI score of 12 or higher
- Psoriasis diagnosed 6 months or more before study entry
- Those who are poorly controlled based on physicians assessment with topical treatments, phototherapy, systemic therapy, or a combination of these therapies.
- Participants who have given informed consent.
You may not qualify if:
- Participants with other systemic illnesses
- Lactating and pregnant mothers.
- Alcohol dependence/Narcotic dependence /Steroid dependence
- In the judgment of the investigator, unable or unwilling to follow the protocol and instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PNNM Ayurveda College
Shōranūr, Kerala, 679 531, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 29, 2019
First Posted
October 31, 2019
Study Start
December 4, 2019
Primary Completion
June 30, 2023
Study Completion
December 31, 2023
Last Updated
June 15, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share